Abstract：
BACKGROUND: Urological consultations for erectile dysfunction (ED) are increasing worldwide. Penile prosthesis (PP) implantations are performed when other treatments are unsuccessful. However, there is no data regarding PP implantations in France beyond the year 2016.
OBJECTIVE: This study aimed to describe the changes in the number and type of PP implants used for the treatment of ED in France from 2016 to 2021 and the hospitalization rates following implantation using French national data from the Program for the Medicalization of Information Systems (PMSI).
METHODS: We analyzed data on PP implantations in all France hospitals. PPs were coded into three types according to the Common Classification of Medical Procedures (CCAM). The number of patients admitted to hospital with complications twelve months after implantation was also recorded.
RESULTS: During the study period, 3675 men received 3868 PPs in France. A gradual increase in the total number of implanted PPs was observed, with an overall increase of 33.8%. In 2020, there was a sharp decline in the number of implanted PPs, primarily owing to the COVID-19 pandemic. The most commonly used implant was PPs with an extracavernous compartment, comprising 85% of all PPs. Twelve months after implantation, only 1-2% of the patients were rehospitalized.
CONCLUSIONS: PP implantation surgeries are highly reproducible and have a low incidence of complications, in terms of rehospitalization after one year of placement (1.8%). Moreover, there was an increase in the demand for penile prosthesis implantations in France between 2016 and 2021.
METHODS: 4: Descriptive epidemiological study.
OBJECTIVE: This study aimed to describe the changes in the number and type of PP implants used for the treatment of ED in France from 2016 to 2021 and the hospitalization rates following implantation using French national data from the Program for the Medicalization of Information Systems (PMSI).
METHODS: We analyzed data on PP implantations in all France hospitals. PPs were coded into three types according to the Common Classification of Medical Procedures (CCAM). The number of patients admitted to hospital with complications twelve months after implantation was also recorded.
RESULTS: During the study period, 3675 men received 3868 PPs in France. A gradual increase in the total number of implanted PPs was observed, with an overall increase of 33.8%. In 2020, there was a sharp decline in the number of implanted PPs, primarily owing to the COVID-19 pandemic. The most commonly used implant was PPs with an extracavernous compartment, comprising 85% of all PPs. Twelve months after implantation, only 1-2% of the patients were rehospitalized.
CONCLUSIONS: PP implantation surgeries are highly reproducible and have a low incidence of complications, in terms of rehospitalization after one year of placement (1.8%). Moreover, there was an increase in the demand for penile prosthesis implantations in France between 2016 and 2021.
METHODS: 4: Descriptive epidemiological study.
摘要：
背景：在世界范围内，勃起功能障碍（ED）的泌尿外科咨询正在增加。当其他治疗不成功时,进行阴茎假体(PP)植入。然而,在2016年之后，没有关于法国PP植入的数据。
目的：本研究旨在描述2016年至2021年法国用于治疗ED的PP植入物的数量和类型的变化以及植入后的住院率使用法国国家数据信息系统医疗计划（PMSI）。
方法：我们分析了所有法国医院的PP植入数据。根据医疗程序通用分类（CCAM）将PP编码为三种类型。还记录了植入后12个月因并发症入院的患者人数。
结果：在研究期间，3675名男子在法国获得了3868名PPs。观察到植入的PPs总数逐渐增加，总体增长33.8%。2020年，植入PPs的数量急剧下降，主要是由于COVID-19大流行。最常用的植入物是带有海绵外腔的PPs，占所有PP的85%。植入后12个月，只有1-2%的患者再次住院.
结论：PP植入手术重复性好，并发症发生率低，安置一年后再住院(1.8%)。此外，2016年至2021年间,法国对阴茎假体植入的需求有所增加.
方法：4：描述性流行病学研究。
目的：本研究旨在描述2016年至2021年法国用于治疗ED的PP植入物的数量和类型的变化以及植入后的住院率使用法国国家数据信息系统医疗计划（PMSI）。
方法：我们分析了所有法国医院的PP植入数据。根据医疗程序通用分类（CCAM）将PP编码为三种类型。还记录了植入后12个月因并发症入院的患者人数。
结果：在研究期间，3675名男子在法国获得了3868名PPs。观察到植入的PPs总数逐渐增加，总体增长33.8%。2020年，植入PPs的数量急剧下降，主要是由于COVID-19大流行。最常用的植入物是带有海绵外腔的PPs，占所有PP的85%。植入后12个月，只有1-2%的患者再次住院.
结论：PP植入手术重复性好，并发症发生率低，安置一年后再住院(1.8%)。此外，2016年至2021年间,法国对阴茎假体植入的需求有所增加.
方法：4：描述性流行病学研究。
